RE:Finally! Easy to parse data! The Best part is that in the Optimized group, they went from
April 5th: at 180 days 40.7% CR and 18.5% PR= totals responders 59.2%
April 29 at 180 days 53% CR and 24% PR= total responders 76%-77%
competition Vicinium was 28% CR at 180 days we are double plus 24% PR who can possibly convert to CR and increase CR of 53% even more.
Recent suggestions by bladder cancer experts suggest that new investigational agents for NMIBC should show at least 45% CR efficacy at 180 days in order to be cost effective vs Cystectomies, if I remember I will post article if I find it. It is great to see that data is improving, we need to maintain this trend from here on and eventually market will catch on. IMHO
DJDawg wrote:
The way they present the data in the MD and A is the way they should have presented it in the news release...and ever time before. Finally!
Here for ease of access
All and optimized
https://postimg.cc/cgj6nLHM
Evaluable
https://postimg.cc/cgj6nLHM